Comparison of the Pathological Effect Between 2 and 4 Cycles Neoadjuvant CAPOX for Low/Intermediate Risk II/III Rectal Cancer | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Comparison of the Pathological Effect Between 2 and 4 Cycles Neoadjuvant CAPOX for Low/Intermediate Risk II/III Rectal Cancer	Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, neoplasm, rectal cancer, rectal disorder, rectal neoplasm	Active, not recruiting	Phase 3	2025-07-11		NCT04922853

15 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Chengdu Fifth People's Hospital	6
Dazhou Central Hospital	3
GeneCast Biotechnology Co., Ltd.	9
Leshan People's Hospital	1
Nanchong Central Hospital	16
Peking Union Medical College	33
Peking University Cancer Hospital & Institute	189
Second Affiliated Hospital, Zhejiang University, School of Medicine	561
Sichuan Provincial People's Hospital	57
Sun Yat-Sen University Cancer Center	74
The Affiliated Hospital Of Guizhou Medical University	33
The First Affiliated Hospital of Zhengzhou University	203
The Third People's Hospital of Chengdu	19
West China Hospital	359
Yunnan Cancer Hospital	46

4 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Genecast Biotechnology Co., Ltd	Wuxi	China	1
The Third Affiliated Hospital of Kunming Medical University	Kunming	China	1
the Third People'S Hospital of Chengdu	Chengdu	China	2
West china hospital	Chengdu	China	9